JP Morgan Chase
AFIB

JP Morgan Chase’s Acutus Medical Inc AFIB Stock Holding History

JP Morgan Chase’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8,965
Closed -$12K – 7013
2022
Q1 		$12K Sell
8,965
-153,289
-94% -$328K ﹤0.01% 6182
2021
Q4 		$553K Buy
162,254
+154,932
+2,116% +$873K ﹤0.01% 4764
2021
Q3 		$65K Buy
7,322
+1,358
+23% +$17.9K ﹤0.01% 5750
2021
Q2 		$101K Sell
5,964
-14,402
-71% -$211K ﹤0.01% 5542
2021
Q1 		$272K Buy
20,366
+13,392
+192% +$302K ﹤0.01% 5019
2020
Q4 		$201K Buy
6,974
+3,108
+80% +$84.1K ﹤0.01% 4808
2020
Q3 		$116K Buy
+3,866
New +$117K ﹤0.01% 4626

Other funds holding AFIB

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $179M AUM 5.77% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase's AFIB Position: Q2 2022 in Review

JP Morgan Chase sold out of Acutus Medical Inc (AFIB) in Q2 2022, closing a stake of 8,965 shares — an estimated $12K sold.

JP Morgan Chase first reported a position in AFIB in Q3 2020 and held it in 7 quarters. The position peaked at $553K in Q4 2021. 47 funds tracked by Wall St. Rank hold AFIB as of Q2 2022.

  • JP Morgan Chase reported no remaining Acutus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • JP Morgan Chase sold 8,965 Acutus Medical Inc shares in Q2 2022, an estimated $12K.
  • JP Morgan Chase first reported a position in Acutus Medical Inc in Q3 2020 and held it in 7 quarters.
  • JP Morgan Chase's Acutus Medical Inc position peaked at $553K in Q4 2021.
  • 47 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2022.

Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.